Columbus Circle Investors’s Acorda Therapeutics ACOR Stock Holding History

Columbus Circle Investors’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,166	Closed	-$5.72M	–	334
2014 Q4	$5.72M	Buy	1,166 +341	+41%	+$1.46M	0.04%	230
2014 Q3	$3.35M	Buy	+825	New	+$3.09M	0.02%	216
2014 Q2	–	Sell	-235	Closed	-$1.07M	–	309
2014 Q1	$1.07M	Sell	235 -99	-30%	-$400K	0.01%	264
2013 Q4	$1.17M	Sell	334 -448	-57%	-$1.75M	0.01%	266
2013 Q3	$3.21M	Buy	782 +515	+193%	+$2.22M	0.02%	263
2013 Q2	$1.06M	Buy	+267	New	+$1.1M	0.01%	258

Other funds holding ACOR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Columbus Circle Investors's ACOR Position: Q1 2015 in Review

Columbus Circle Investors sold out of Acorda Therapeutics (ACOR) in Q1 2015, closing a stake of 1,166 shares — an estimated $5.72M sold.

Columbus Circle Investors first reported a position in ACOR in Q2 2013 and held it in 6 quarters. The position peaked at $5.72M in Q4 2014. 190 funds tracked by Wall St. Rank hold ACOR as of Q1 2015.

Columbus Circle Investors reported no remaining Acorda Therapeutics position as of Q1 2015 after selling out during the quarter.
Columbus Circle Investors sold 1,166 Acorda Therapeutics shares in Q1 2015, an estimated $5.72M.
Columbus Circle Investors first reported a position in Acorda Therapeutics in Q2 2013 and held it in 6 quarters.
Columbus Circle Investors's Acorda Therapeutics position peaked at $5.72M in Q4 2014.
190 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2015.

Based on Columbus Circle Investors's 13F filing for Q1 2015, filed 30 Apr 2015.